GHRP-6 peptide UK, supplied at 10mg strength. A synthetic GH secretagogue hexapeptide, manufactured to high purity and independently batch tested. For laboratory research use only.
GHRP-6 peptide UK is Crown Peptides’ synthetic hexapeptide growth-hormone secretagogue, available in 10mg strength for laboratory research.
GHRP-6 is a synthetic six-amino-acid peptide and one of the classic growth-hormone-releasing peptides. Its research activity is associated primarily with the growth-hormone secretagogue receptor, also known as the ghrelin receptor or GHSR.
GHRP-6 is studied in endocrine and receptor-pharmacology models involving GHSR activation, pituitary growth-hormone release and appetite-associated signalling. It is historically important in growth-hormone secretagogue research because it helped demonstrate that ghrelin-receptor pathways can regulate pituitary signalling independently of the GHRH receptor (Learn more), alongside related secretagogue peptides such as [Ipamorelin] and [CJC-1295 with DAC].
Research context: the GHRP-6 research areas described above reflect laboratory, preclinical or published scientific investigation. They should not be interpreted as established therapeutic effects, medical claims or approved human uses.
Crown Peptides GHRP-6 is supplied for controlled laboratory research with batch-specific analytical documentation. High-Performance Liquid Chromatography (HPLC) can assess chromatographic purity, while Mass Spectrometry provides molecular information used to support identity verification.
The batch-specific Certificate of Analysis is the definitive source for the exact purity result, identity data and analytical specification of the material supplied.
What is GHRP-6?
GHRP-6 is a synthetic hexapeptide growth-hormone secretagogue studied through the ghrelin/GHSR receptor system, supplied by Crown Peptides at 10mg strength.
What receptor does GHRP-6 act on in research models?
Its primary research target is the growth-hormone secretagogue receptor, commonly called GHSR or the ghrelin receptor.
What is GHRP-6 researched for?
Research includes receptor pharmacology, pituitary growth-hormone release, endocrine signalling and appetite-associated pathways.
How is GHRP-6 different from a GHRH analogue?
GHRP-6 acts mainly through the ghrelin/GHSR pathway, whereas GHRH analogues such as [CJC-1295 with DAC] act through the GHRH receptor.
How is GHRP-6 tested?
Peptide purity and identity can be evaluated using HPLC and Mass Spectrometry, with the exact batch results shown on the CoA.
Researchers working with GHRP-6 may also be interested in [Ipamorelin], [CJC-1295 with DAC], [CJC-1295 + Ipamorelin], [Sermorelin] and [Tesamorelin] — other growth-hormone-releasing peptides studied in the same endocrine research pathway.
Each batch undergoes internal analytical verification using chromatographic and spectrometric methods prior to lyophilisation.
• HPLC Analysis
• Mass Spectrometry Confirmation
• Batch Traceability
By purchasing this product you confirm that you are a qualified researcher and that this compound will be used exclusively for laboratory research purposes.
This product is not intended for diagnostic or therapeutic use.
Any human or medical use is strictly prohibited.
Store in a cool, dry, secure and sterile environment away from any unauthorised persons or children.